How the world’s first weekly insulin shot could change diabetes treatment in India
Novo Nordisk launched the world's first weekly insulin shot, icodec, in India, aimed at simplifying diabetes management by reducing daily injections to just one per week. This innovation is expected to enhance treatment adherence for the 101 million people living with diabetes in the country. Priced at ₹261 per week, the drug represents a significant advancement in insulin therapy, potentially improving the quality of life for many patients.